66 related articles for article (PubMed ID: 3779632)
21. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
23. Effect of chemotherapeutic agents on the formation of estrogen-receptor complex in human breast tumor cytosol.
Müller RE; Sheard BE; Traish A; Wotiz HH
Cancer Res; 1980 Aug; 40(8 Pt 1):2941-2. PubMed ID: 7388845
[TBL] [Abstract][Full Text] [Related]
24. Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors.
Mercer WD; Edwards DP; Chamness GC; McGuire WL
Cancer Res; 1981 Nov; 41(11 Pt 1):4644-52. PubMed ID: 7030480
[TBL] [Abstract][Full Text] [Related]
25. Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach.
Itoh T; Karlsberg K; Kijima I; Yuan YC; Smith D; Ye J; Chen S
Mol Cancer Res; 2005 Apr; 3(4):203-18. PubMed ID: 15831674
[TBL] [Abstract][Full Text] [Related]
26. The effect of oestrogens and medroxyprogesterone acetate on the uptake of cytotoxic drugs by MCF-7 breast cancer cells.
Reed MJ; Ross MS; Ghilchik MW
Anticancer Res; 1992; 12(2):533-6. PubMed ID: 1533753
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of estrogen receptors by nonsteroidal antiestrogens in human breast cancer.
Kiang DT; Kollander RE; Thomas T; Kennedy BJ
Cancer Res; 1989 Oct; 49(19):5312-6. PubMed ID: 2766299
[TBL] [Abstract][Full Text] [Related]
28. Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens.
Osborne CK; Kitten L; Arteaga CL
J Clin Oncol; 1989 Jun; 7(6):710-7. PubMed ID: 2715802
[TBL] [Abstract][Full Text] [Related]
29. Effects of type I and II interferons on cultured human breast cells: interaction with estrogen receptors and with tamoxifen.
Goldstein D; Bushmeyer SM; Witt PL; Jordan VC; Borden EC
Cancer Res; 1989 May; 49(10):2698-702. PubMed ID: 2469536
[TBL] [Abstract][Full Text] [Related]
30. Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture.
Nawata H; Chong MT; Bronzert D; Lippman ME
J Biol Chem; 1981 Jul; 256(13):6895-902. PubMed ID: 7240250
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapeutic agents and estradiol receptor binding capacity.
Görlich M; Heise E; Számel I; Kerpel-Fronius S
Oncology; 1979; 36(4):149-55. PubMed ID: 471426
[TBL] [Abstract][Full Text] [Related]
32. The effectiveness of clinically useful antitumor agents as inhbitors of RNA polymerases.
Hill BT
Cancer Biochem Biophys; 1977; 2(1):43-50. PubMed ID: 616320
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of the cytocidal activity and uptake of melphalan by tamoxifen in human breast cancer cells in vitro.
Goldenberg GJ; Froese EK
Biochem Pharmacol; 1985 Mar; 34(6):763-70. PubMed ID: 3977953
[TBL] [Abstract][Full Text] [Related]
34. Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.
Bernhardt G; Reile H; Birnböck H; Spruss T; Schönenberger H
J Cancer Res Clin Oncol; 1992; 118(1):35-43. PubMed ID: 1309532
[TBL] [Abstract][Full Text] [Related]
35. Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleate.
Foster BJ; Grotzinger KR; McKoy WM; Rubinstein LV; Hamilton TC
Cancer Chemother Pharmacol; 1988; 22(2):147-52. PubMed ID: 3409446
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory and cytotoxic effects of Oncovin (Vincristine sulfate) on cells of human line NHIK 3025.
Dahl WN; Oftebro R; Pettersen EO; Brustad T
Cancer Res; 1976 Sep; 36(9 pt.1):3101-5. PubMed ID: 987848
[TBL] [Abstract][Full Text] [Related]
37. A diphenylmethane derivative selective for the anti-estrogen binding site may help define its biological role.
Brandes LJ
Biochem Biophys Res Commun; 1984 Oct; 124(1):244-9. PubMed ID: 6548626
[TBL] [Abstract][Full Text] [Related]
38. The dilemma of estrogen receptors and the response rate to cytotoxic chemotherapy. A problem of comparability analysis.
Carter SK
Cancer Clin Trials; 1979; 2(1):49-53. PubMed ID: 519831
[TBL] [Abstract][Full Text] [Related]
39. Phenylacetic acid halides inhibit estrogen receptor (ER)-positive MCF-7 cells, but not ER-negative human breast cancer cells or normal breast epithelial cells.
Johnson DE; Ochieng J; Evans SL
Anticancer Drugs; 1996 May; 7(3):288-92. PubMed ID: 8792002
[TBL] [Abstract][Full Text] [Related]
40. Effect of antineoplastic drugs and estradiol on leucine uptake and proliferation of Ehrlich tumor cells.
Levin E; Cherñavsky A
Biomed Pharmacother; 1989; 43(3):215-7. PubMed ID: 2775858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
